Showing results (41-50 of 261) with videos related to
Sort By:
Pageof 27
Journal of Hepatology|March 1, 1993
Controlled trial of antithrombin III supplementation in fulminant hepatic failureP G Langley, R D Hughes, A Forbes, et al.Journal of Cutaneous Medicine and Surgery|July 3, 2007
Biologic therapeutics in the treatment of psoriasis. Part 2: practical considerationsRichard G Langley, Aditya K Gupta, Andrea M Cherman, et al.Journal of Cutaneous Medicine and Surgery|May 22, 2007
Biologic therapeutics in the treatment of psoriasis. Part 1: reviewRichard G Langley, Aditya K Gupta, Andrea M Cherman, et al.Journal of Hepatology|September 10, 2002
Thiopurine methyltransferase phenotype and genotype in relation to azathioprine therapy in autoimmune hepatitisPeter G Langley, James Underhill, J Michael Tredger, et al.Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 1, 1994
Hepatocyte growth factor and plasminogen activation in fulminant hepatic failureJ R Pernambuco, R D Hughes, P G Langley, et al.Thrombosis and Haemostasis|October 30, 1985
Heparin response and clearance in acute and chronic liver diseaseH Sette, R D Hughes, P G Langley, et al.Contraception|October 24, 2001
Weight change and adverse event incidence with a low-dose oral contraceptive: two randomized, placebo-controlled trialsP Coney, K Washenik, R G Langley, et al.Metabolism: Clinical and Experimental|December 6, 2001
Beneficial effects of metformin in normoglycemic morbidly obese adolescentsJ P Kay, R Alemzadeh, G Langley, et al.Journal of Cutaneous Medicine and Surgery|October 6, 2009
Biologics in the treatment of psoriasis: clinical and economic overviewYves Poulin, Richard G Langley, Henrique D Teixeira, et al.Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1995
Acute phase response after liver transplantation for fulminant hepatic failure and cirrhosisS Izumi, R D Hughes, P G Langley, et al.Pageof 27